¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"permissible radiation exposure level"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • public exposure
    °ø°øÇÇÆø, °ø°ø³ëÃâ
  • subanesthetic exposure
    Áظ¶Ãë³ëÃâ
  • sun exposure
    ÇÞºû³ëÃâ, Àϱ¤³ëÃâ
  • short term exposure
    ´Ü±â³ëÃâ
  • acceptable noise level
    Çã¿ë¼ÒÀ½¼öÁØ
  • antimicrobial level
    Ç×±Õ¼öÁØ
  • audiometric level
    û·Â¼öÁØ
  • air fluid level
    °ø±â¾×üÃþ
  • alertness level
    °¢¼º¼öÁØ
  • background level
    ¹è°æ¼öÁØ
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • radiation field
    ¹æ»ç¼±Á¶»ç¿µ¿ª
  • radiation injury
    ¹æ»ç¼±¼Õ»ó
  • radiation necrosis
    ¹æ»ç¼±±«»ç
  • radiation protection
    ¹æ»ç¼±¹æ¾î
  • radiation
    1.¹æ»ç¼±, 2.¹æ»ç, ºÎê»ì
  • ionizing radiation
    ÀÌ¿ÂÈ­¹æ»ç¼±
  • radiation resistance
    ¹æ»ç¼±ÀúÇ×
  • scattered radiation
    »ê¶õ¹æ»ç¼±
  • whole-body radiation
    Àü½ÅÁ¶»ç
  • radiation sickness
    ¹æ»ç¼±º´
  • radiation shield
    ¹æ»ç¼±º¸È£±¸, ¹æ»ç¼±Â÷Æó
  • radiation therapy
    ¹æ»ç¼±¿ä¹ý, ¹æ»ç¼±Ä¡·á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • exposure rate
    ÇÇÆø·ü
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • occupational exposure
    Á÷¾÷³ëÃâ
  • prolonged exposure
    Àå±â³ëÃâ
  • public exposure
    °øÁßÇÇÆø, °øÁß³ëÃâ
  • short term exposure
    ´Ü±â³ëÃâ
  • subanesthetic exposure
    Áظ¶Ãë³ëÃâ
  • sun exposure
    Àϱ¤³ëÃâ
  • acceptable noise level
    Çã¿ë¼ÒÀ½¼öÁØ
  • air fluid level
    °ø±â¾×üÃþ
  • alertness level
    °¢¼º¼öÁØ
  • antimicrobial level
    Ç×±Õ¼öÁØ
  • audiometric level
    û·Â¼öÁØ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acoustic radiation =auditory r.
    û¹æ»ç
  • acute radiation dermatitis
    ±Þ¼º ¹æ»ç¼± ÇǺο°
  • acute radiation sickness
    ±Þ¼º¹æ»ç¼±Áõ
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº(¡­Û¯ÞÒàÊñøý¦ÏØ)
  • adaptive radiation therapy
    ÀûÀÀ¹æ»ç¼±Ä¡, ¼øÀÀ¹æ»ç¼±Ä¡·á
  • annihilation radiation
    ¼Ò¸ê¹æ»ç¼±
  • fractionated stereotactic radiation therapy
    ºÐÇÒÁ¤À§ ¹æ»ç¼±Ä¡·á
  • heat radiation
    ¿­¹æ»ç(ËçËÑË×).
  • heat radiation
    ¿­¹æ»ç(æðÛ¯ÞÒ).
  • high energy radiation
    °í¿¡³ÊÁö¹æ»ç¼±
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • homogenous radiation
    ±ÕÀϹæ»ç¼±
  • indirectly ionizing radiation
    °£Á¢Àü¸®¹æ»ç¼±
  • infrared radiation
    Àû¿Ü¹æ»ç¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • exposure calibration factor
    ÇÇÆøÃøÁ¤°è¼ö
  • exposure dose
    Á¶»ç·®.
  • exposure keratitis
    ³ëÃâ°¢¸·¿°(ÖÚõóÊÇØ¯æú).
  • exposure keratopathy
    ³ëÃâ°¢¸·º´Áõ
  • exposure meter
    ³ëÃâ°è(ËȨ̀˭).
  • exposure of person
    ½Åü ³ëÃâ.
  • exposure rate
    ÇÇÆøÀ²
  • exposure rate constant
    ÇÇÆøÀ²»ó¼ö
  • exposure suits
    ³»Çѳ»¼öº¹(ËÀ̰ËÀËàËÓ).
  • exposure therapy
    ³ëÃâ¿ä¹ý(ÒËõóÖûÛö)
  • exposure time
    Æø·Î½Ã°£.
  • external exposure
    ¿ÜºÎÇÇÆø
  • internal exposure
    ü³»ÇÇÆø
  • occupational exposure
    Á÷¾÷¼º ³ëÃâ.
  • occupational exposure
    Á÷¾÷ÇÇÆø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radiation biochemistry
    ¹æ»ç¼± »ýÈ­ÇÐ(Û¯ÞÒàÊßæûùùÊ)
  • radiation chimera
    ¹æ»ç¼±(Û¯ÞÒàÊ) Ű¸Þ¶ó
  • radiation curing
    ¹æ»ç¼± óġ(ô¥öÇ)[ÂÉÀÓ]
  • radiation dose
    ¹æ»ç¼±·®(Û¯ÞÒàÊÕá)
  • radiation sickness
    ¹æ»ç¼±º´(Û¯ÞÒàÊÜ»)
  • radioactive radiation
    ¹æ»ç¼º Á¶»ç(º¹»ç)(Û¯ÞÒàõðÎÞÒ(ÜßÞÒ))
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • level
    ´ë, ¼öÁØ
  • sedimentation level
    ħÀüÃþ
  • window level
    â³ôÀÌ
  • background radiation
    ¹è°æ¹æ»ç¼±
  • braking radiation
    ÀúÁö¹æ»ç¼±
  • characteristic radiation
    Ư¼º¹æ»ç¼±
  • cosmic radiation
    ¿ìÁÖ¹æ»ç¼±
  • dipole radiation
    ½Ö±Ø¹æ»ç¼±
  • electromagnetic radiation
    ÀüÀÚÆÄ¹æ»ç¼±
  • high energy radiation
    °íÀü¾ÐÁ¶»ç
  • homogeneous radiation
    ±ÕÁú¹æ»ç¼±
  • infrared radiation
    Àû¿Ü¹æ»ç¼±
  • ionizing radiation
    Àü¸®¹æ»ç¼±
  • laser [=light amplification by stimulated emission of radiation]
    ·¹ÀÌÀú
  • leakage radiation
    ´©Ãâ¹æ»ç¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
REL rate of energy loss; recommended exposure limit; resting expiratory level
ALARA as low as reasonably achievable [radiation exposure]
REG radiation exposure guide; radioencephalogram, radioencephalography
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
CCL carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FAE Fetal alcohol exposure
JEM Job Exposure Matrix
LDEF Long Duration Exposure Facility
MEP Multiple exposure photography
NHEXAS National Human Exposure Assessment Survey
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fasting blood sugar level
    °øº¹ ½Ã Ç÷´çÄ¡
  • level
    ¼öÁØ, ±íÀÌ, Ä¡, ´ÜÀ§, Ãþ, À§, ³ôÀÌ, ¹üÀ§, ¼öÁرâ, ÁØÀ§
  • maximal expiratory level
    ÃÖ´ë È£±âÀ§
  • maximal inspiratory level
    ÃÖ´ë Èí±âÀ§
  • mucosal level
    Á¡¸· ¼öÁØ
  • subconscious level
    ÀáÀç ÀÇ½Ä ¼öÁØ
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­
  • ultrastructural level
    Ãʹ̼¼ ±¸Á¶Àû ¼öÁØ
    ÀÎü¸¦ ±¸¼ºÇÏ´Â ÃÖ¼Ò ¹Ì¼¼ ÀÔÀÚÀÇ ¼öÁØ. ±¤ÇÐÇö¹Ì°æÀÇ ÇØ»ó·ÂÀ» ³ÑÀº ÃÊÇö¹Ì°æÀ̳ª ÀüÀÚÇö¹Ì°æÇÏ¿¡¼­ óÀ½À¸·Î º¸ÀÌ´Â ±¸Á¶.
  • acute exposure
    ±Þ¼º ÇÇÆø
    ¹æ»ç¼± °Ç°­°ü¸®Çлó »ç¿ëµÇ´Â ¿ë¾îÀÌ°í ¹æ»ç¼± »ç°í µî, ºñ±³Àû ªÀº ½Ã°£¿¡ °íü°¡ ÇÇÆøÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. Á÷¾÷ÀûÀ¸·Î ¾Æ¹«·¡µµ ÇÇÇÒ ¼ö ¾ø´Â ÇÇÆøÀ̳ª ½ºÆ®·ÐƬÀÇ »À¿¡ ´ëÇÑ Ä§Âø µî Àå¹Ý°¨±âÀÇ ¹æ»ç¼± µ¿À§¿ø¼Ò°¡ ¸ö ¾È¿¡ µé¾î°£ °æ¿ìÀÇ ÇÇÆøÀ» ¸¸¼º ÇÇÆøÀ̶ó°í ¸»Çϴµ¥ ´ëÇØ¼­ À̰°ÀÌ ¸»ÇÑ´Ù.
  • chemical exposure
    È­ÇÐÀû ³ëÃâ
  • chronic exposure
    ¸¸¼º ³ëÃâ
  • double exposure technique
    Áߺ¹ X¼± ÃÔ¿µ¼ú
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • exposure dose
    Á¶»ç·®
  • exposure threshold
    ³ëÃâ ÇѰèÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
ACE level <investigation> This is a blood test which measures the concentration of angiotensin-converting enzyme (ACE) in the bloodstream.
Elevations in angiotensin-converting enzyme are seen sarcoidosis, histoplasmosis, alcoholic cirrhosis, asbestosis, berylliosis, diabetes, Hodgkin's disease, hyperthyroidism, amyloidosis, primary biliary cirrhosis, idiopathic pulmonary fibrosis, pulmonary embolism, scleroderma, silicosis, tuberculosis, Gaucher's disease and leprosy.
The normal values are 18 to 67 U/ml over 20 years of age (people under 20 have higher levels).
(15 Jan 1998)
acoustic reference level The biological reference level for sound measurements. When the term decibel is used to indicate the noise level, a reference quantity is implied; this reference value is usually expressed as a sound pressure of 20 micronewtons per square meter. The reference level is referred to as 0 decibels, the baseline of the scale of noise level's; this baseline is considered the weakest sound that can be heard by a person with very good hearing in an extremely quiet location. Other equivalent reference level's still being used include 0.0002 microbar and 0.0002 dyne per square centimeter.
(05 Mar 2000)
background level The average amount of a substance present in the environment. Originally referring to naturally occurring phenomena. Used in toxic substance monitoring.
(05 Dec 1998)
blood porphyrin level A test which is used to measure red blood cell porphyrin levels. Porphyrins are pigments found in both animal and plant life.
This test is useful in evaluating any number of porphyrin disorders (involving the various porphyrins) of red blood cells.
Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia.
Increased protoporphyrins may be seen in infection, thalassaemia, sideroblastic anaemia, iron deficient anaemia, increased erythropoiesis and lead poisoning. Increased uroporphyrins may indicate congenital erythropoietic porphyria or erythropoietic protoporphyria.
(27 Sep 1997)
carbon dioxide blood level A measure of the bicarbonate level in the blood based on a venipuncture specimen. The serum carbon dioxide is one of the normally reported values in the electrolytes profile. Lower levels of carbon dioxide indicate an acidosis. The normal level is 20 to 29 mEq/L. Lower than normal levels can indicate diabetic ketoacidosis, lactic acidosis, alcoholic ketoacidosis, kidney disease, renal failure, diarrhoea, Addison's disease, ethylene glycol poisoning or methanol poisoning. Greater than normal levels can be seen with excessive vomiting, hyperaldosteronism and Cushing's syndrome.
(27 Sep 1997)
vasopressin level This test measures the amount of ADH in the serum. It is used to detect disorders that may affect the level of ADH in the serum. Normal values are: 0 to 4.7 pg/ml. Elevated ADH levels can indicate a CNS infection, fluid imbalance, CNS tumour, SIADH or acute porphyria. Low levels can indicate: diabetes insipidus or damage to the pituitary gland.
(27 Sep 1997)
mean sea level <marine biology> A tidal datum: the arithmetic mean of hourly water elevations observed over a specific 19-year cycle. Points on land can be referenced to a mean sea level, in which case the datum assumes zero elevation.
(09 Oct 1997)
gray level also gray value <microscopy> The brightness of pixels in a digitised video image, commonly expressed in integers ranging from 0 (black) to 255 (white) for an 8-bit digital signal.
(05 Aug 1998)
gray level histogram <microscopy> In digital image processing, a histogram that depicts the number of pixels at each gray value. The histogram can be used to measure the areas that have given ranges of gray values or to adjust image contrast by histogram stretching or equalisation.
See: Image histogram.
(05 Aug 1998)
Clark's level The level of invasion of primary malignant melanoma of the skin; limited to the epidermis, I; into the underlying papillary dermis, II; to the junction of the papillary and reticular dermis, III; into the reticular dermis, IV; into the subcutaneous fat, V. The prognosis is worse with each successive deeper level of invasion.
(05 Mar 2000)
cohb level A blood test which is performed on an arterial specimen and is a measurement of the amount of carbon monoxide which is present and bound to haemoglobin. This is an important test to diagnosis carbon monoxide toxicity (smoke inhalation). Normal carboxyhaemoglobin may be from 3% to as high as 12% in heavy smokers.
Symptoms of carbon monoxide poisoning begin at about 20% carboxyhaemoglobin.
(27 Sep 1997)
white level <microscopy> Also reference white level. The IEEE scale, or voltage level, of the video picture signal that corresponds to a specified maximum limit for white peaks.
(05 Aug 1998)
window level The CT number setting in Hounsfield units of the midpoint of the window width, which is the gray scale of the image; a typical window level for imaging the lungs if -500; for the abdomen, 0.
(05 Mar 2000)
hearing level The measure of the status of hearing as read directly on the hearing loss scale of an audiometer; described in decibels as a deviation from a standard value for zero on the audiometer.
(05 Mar 2000)
serum iron level A test that measures the amount of iron (Fe ++) in the blood. The test is performed when iron deficiency is suspected. Normal serum iron is 60 to 170 mcg/dl. Increased levels may be seen in the following: haemochromatosis, haemolysis, haemolytic anaemia, hepatitis, liver necrosis, haemosiderosis, iron poisoning and lead toxicity. Lower than normal levels are seen in chronic GI blood loss, iron deficiency anaemia, insufficient dietary iron, malabsorption, chronic heavy menstrual bleeding, nephrosis and late pregnancy.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dumpy level
    ¸Á¿ø°æÀÌ ´Þ¸° ¼öÁرâ
  • fog level
    (Çö»óµÈ Çʸ§ÀÇ) ¹Ì³ëÃâ ³óµµ
  • level
    ¼öÆòÀÇ;ÆòÆòÇÑ;µ¿ÀÏ ¼öÁØÀÇ;¼­·Î ¿ì¿­ÀÌ ¾ø´Â;ÇѰᰰÀº;ºÐº°ÀÖ´Â;do one's ~ best Àü·ÂÀ» ´ÙÇÏ´Ù
  • level
    ¼öÆò(¸é);ÆòÁö;³ôÀÌ;¼öÁØ;find one's(its)~ ½Ç·Â¿¡ ¸Â´Â ÁöÀ§¸¦ ¾ò´Ù;on a ~ with ...°ú µ¿µîÇϰÔ;on the ~ °øÁ¤ÇÑ
  • level
    °Ü´©´Ù;Á¶ÁØÇÏ´Ù;~ down(up)(...ÀÇ Ç¥ÁØÀ») ³·Ãß´Ù(¿Ã¸®´Ù)
  • level
    ¼öÆòÀ¸·Î ¸¸µé´Ù;°í¸£´Ù;µ¿ÀÏ ¼öÁØÀ¸·Î ¸¸µé´Ù;(°Ç¹°À») ¾²·¯¶ß¸®´Ù;(Àǵµ¸¦) µ¹¸®´Ù
  • mean sea level
    Æò±Õ ÇØ¸é(ÇØ¹ß ±âÁØ)
  • ordinary level
    G;C;E;ÀÇ ±âÃÊ Çз ½ÃÇè
  • replacement level
    Àα¸ º¸Ãæ ¼öÁØ(ÃÑÀα¸¸¦ À¯ÁöÇÏ´Â µ¥¿¡ ÇÊ¿äÇÑ Ãâ»ý·ü)
  • resistance level
    (½Ã¼¼ÀÇ)ÀúÇ×¼±(½Ã¼¼°¡ ÁÁ±â ¶§¹®¿¡ ÆÇ¸Å°¡ Ȱ¹ßÇØÁ®,±× ÀÌ»óÀÇ ½Ã¼¼ »ó½ÂÀÌ µÐÇØÁö´Â °¡°Ý ¼öÁØ)
  • sea level
    ÇØ¸é
  • spirit level
    ÁÖÁ¤ ¼öÁرâ
  • water level
    ¼öÆò¸é
  • radiation
    ¹ß±¤
  • C(h)erenkov radiation
    ü·»ÄÚÇÁ ¹æ»ç¼±(¹°Áú ¼ÓÀ» ÇÏÀüÀÔÀÚ°¡ °í¼Óµµ·Î Åë°úÇÒ¶§ ÀϾ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á